Browse > Article

A Case of Pyomyositis and Toxic Shock Syndrome Caused by Methicillin Resistant Staphylococcus aureus  

Kim, Yang Kyong (Department of Pediatrics, College of Medicine, Inha University)
Kim, Dal Hyon (Department of Pediatrics, College of Medicine, Inha University)
Kim, Soon Ki (Department of Pediatrics, College of Medicine, Inha University)
Son, Byong Kwan (Department of Pediatrics, College of Medicine, Inha University)
Hong, Young Jin (Department of Pediatrics, College of Medicine, Inha University)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.1, 2005 , pp. 88-92 More about this Journal
Abstract
Pyomysitis is a primary acute bacterial infection of large skeletal muscule, usually occuring in the absence of specific cause of infection. Pyomyositis has been reported mainly in tropical countries and was rare in temperate climates. but it has been recognized with increasing frequency. Toxic shock syndrome(TSS) is an acute mutisystemic disease characterized by high fever, hypotension, multisystem dysfunction and erythematous rash followed by skin desquamation 8-12 days after onset. Especially, TSS and pyomyositis are rare conditions in the pediatric population. We experienced one case in a healthy 13-year-girl who developed pyomyositis of the right ileac and gluteal muscles associated with TSS caused by methicillin resistant Staphylococcus aureus. We reports a case of acute pyomyositis with TSS, in which the diagnosis was difficult because of the relative rare incidence in temperate climates and its vague symptoms. To our knowledge, this is the first reported case of pyomyositis with TSS in Korean pediatric population.
Keywords
Myositis; Toxic shock syndrome; Staphylococcus aureus; Methicillin resistance;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Todd J, Fishaut M, Kapral F, Welch T. Toxic shock syndrome associated phage-group I staphylococci. Lancet 1978; 2:1116-8
2 Bartlett P, Reingold AL, Graham DR, Dan BB, Selinger DS, Tank GW, et al. Toxic shock syndrome associated with surgical wound infections JAMA 1982;247:1448-50   DOI   ScienceOn
3 Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome CV. Nonmenstrual toxic shock syndrome : a review of 130 cases. Ann Intern Med 1982;96:871   DOI   ScienceOn
4 Gibson RK, Rosenthal SJ, Lukert BP. Pyomyosistis increasing recognition in temperate climates. Am J Med 1984;77:768-72   DOI   ScienceOn
5 Jayoussi R, Bialik V, Eyal A, Shehadeh N, Etzioni A. Pyomyositis caused by vigorous exercise in a boy. Acta Paediatr 1995;84:226-7   DOI   ScienceOn
6 Rich RR. Intravenous IgG : supertherapy for superantigens. J Clin Intravest 1993;91:378   DOI   ScienceOn
7 Wolfe MW, Bennett JT. Pyomyositis with toxic shock syn- drome presenting as back pain and fever. Am J Orthop 1997;26:135-7
8 Ko SH, Park SO, Choi YW, Kim DK, Jung KS, Leu JS, et al. 1 case of pyomyositis. Infect Chemother 1999;22:261-6
9 Immerman RP, Greenman RL. Toxic shock syndrome associated with pyomyositis caused by a strain of Staphylococcus aureus that doses not produce toxic shock syndrome toxin-1. J Infect Dis 1987;156:505-7   DOI   ScienceOn
10 Chesney PJ, Davis JP. Toxic shock syndrome. In : Feigin RD, Cherry JD, editors. Text book of pediatric infectious disease 5th ed. Philadelphia : WB Saunders Co, 2004:836-59
11 McKenna UG, Meadows JA III, Brewer NS, Wilson WR, Perrault J. Toxic shock syndrome, a newly recognized disease entity : report of 11 cases. Mayo Clin Proc 1980;55: 663-72
12 Todd JK. Toxic shock syndrome In: Long SS, Pickering LK, Prober CG, editors. Principles and practice of pediatric infectious disease 2nd ed. Philadelphia : Churchill Livingstone Co, 2003:99-102
13 Hackett SP, Stevens DL. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. J Infect Dis 1993;168:232-5   DOI   ScienceOn
14 Gahrn-Hansen B, Lundkvist L, Nielsen E. Pyomyositis and probable toxic shock syndrome caused by a toxin-1 producing strain of Satphylococcus aurues. Eur J Clin Microbiol Infect Dis 1989;8:89-90   DOI   ScienceOn
15 Grose C. Pyomyositis and Bacterial myositis. In : Feigin RD, Cherry JD, editors. Text book of pediatric infectious disease 5th ed. Philadelphia : WB Saunders Co, 2004:737-41
16 Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993;167:997-1002   DOI   ScienceOn
17 Gubbay AJ, Isaacs D. Pyomyositis in children. Pediatr Infect Dis J 2000;19:1009-13   DOI   ScienceOn
18 Nizet V. Myositis and pyomyositis. In : Long SS, Pickering LK, Prober CG, editors. Principles and practice of pediatric infectious disease 2nd ed. Philadelphia : Churchill Livingstone Co, 2003:458-62
19 Wiesenthal AM, Todd JK. Toxic shock syndrome in children aged 10 years or less. Pediatrics 1984;74:112-7
20 Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic shock syndrome : epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980;303:1429-35   DOI   ScienceOn
21 Scriba J. Beitrag zur aeiologe der myositis acuta. Dtsch A Chir 1885;22:197-202
22 Han SH, Yoon JW, Chung HJ, Kim WJ, Kim MJ, Park SC et al. Klebsiella pyomyositis in a diabetic man. Infect Chemother 1995;3:295-9
23 Chiedozi LC. Pyomyositis, review of 205 cases in 112 patients. Am J Surg 1979;137:255-9   DOI   ScienceOn